Javier Costas
Lead researcher of the Psychiatric Genetics group at the Health Research Institute of Santiago de Compostela (IDIS) and member of the Research Network on Addiction Primary Care (RIAPAd)
This is an exploratory study with limited statistical power; consequently, many of the results may not be confirmed in subsequent analyses. The more conventional analysis, which seeks associations with methylation at the DNA position level, does not yield any notable results given the study’s limited statistical power.
The authors summarise the variability in methylation levels across the entire sample in the three brain regions, identifying latent factors (not measured directly) that encapsulate this variability. Several of these factors are associated with individual characteristics whose effect on methylation levels is well known, such as age, cell type composition or sex. Other individual characteristics with some evidence of affecting methylation levels were diagnosis and exposure to traumatic experiences. However, due to the small sample size, it was not possible to go beyond detecting the general effect, without identifying specific genes involved. Nevertheless, this is significant as it lays the groundwork for subsequent, more powerful studies that may identify genes and biological functions associated with differences in methylation levels resulting from traumatic experiences.
A clear limitation of the study is that it does not take into account many important individual characteristics, such as medication, alcohol use and other drugs. It should be borne in mind that a very significant proportion of patients with post-traumatic stress disorder (PTSD) have psychiatric (primarily depression) and substance-use comorbidities. Therefore, by failing to account for these variables, the results may identify mechanisms that are more closely related to these consequences of suffering from PTSD than to the pathophysiology of the disorder itself.
Finally, the findings regarding the different proportion of oligodendrocytes in patients with post-traumatic stress disorder are supported by genomic studies—which the authors have overlooked—indicating that genetic susceptibility to the disorder is concentrated not only in genes important for neuronal physiology, but also in those involved in oligodendrocyte physiology.